Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itraconazole versus itraconazole + isotretinoin for tinea infection
ACTRN12626000004369Phase 2Active, not recruiting
- Sponsor
- PNS Shifa
- Start
- Aug 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in tinea comparing Itraconazole monotherapy with Itraconazole + isotretinoin (2 arms). Primary endpoints: Complete clinical and mycological cure, Total Symptom Score and 2 more. Started Aug 2025; status: active, not recruiting.
02
Drugs
itraconazoleisotretinoin
03
Conditions
tinea
Beyond the preview
Go deeper on ACTRN12626000004369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12626000004369.